REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Kreanova Pharmaret (Indonesia)

Main Activities: All Other Miscellaneous Store Retailers (except Tobacco Stores)
Full name: PT Kreanova Pharmaret Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Kreanova Pharmaret is an enterprise in Indonesia, with the main office in Central Jakarta. The enterprise operates in the All Other Miscellaneous Store Retailers (except Tobacco Stores) industry. The enterprise was incorporated on 1954. It currently has a total number of 40 (2018) employees. The latest financial highlights indicate a net sales revenue increase of 12.8% in 2022. Its’ total assets recorded a growth of 15.37%.

Headquarters
Kota Jakarta Pusat Cideng Gambir Dki Jakarta
Central Jakarta; Jakarta; Postal Code: 10150

Contact Details: Purchase the PT Kreanova Pharmaret report to view the information.

Website: http://www.apotekroxy.com

Basic Information
Total Employees:
Purchase the PT Kreanova Pharmaret report to view the information.
Outstanding Shares:
Purchase the PT Kreanova Pharmaret report to view the information.
Registered Capital:
Purchase the PT Kreanova Pharmaret report to view the information.
Incorporation Date:
1954
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Kreanova Pharmaret report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
12.8%
Total operating revenue
12.8%
Total assets
15.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?